Chemoinformaics analysis of 1alpha-Methoxy-1,2-Dihydroazadiradione
| Molecular Weight | 498.616 | nRot | 3 |
| Heavy Atom Molecular Weight | 460.312 | nRig | 30 |
| Exact Molecular Weight | 498.262 | nRing | 6 |
| Solubility: LogS | -3.934 | nHRing | 2 |
| Solubility: LogP | 3.203 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 5 |
| nHA | 7 | APOL | 79.3821 |
| nHD | 0 | BPOL | 47.6699 |
| QED | 0.448 |
| Synth | 5.792 |
| Natural Product Likeliness | 3.156 |
| NR-PPAR-gamma | 0.939 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.988 |
| Pgp-sub | 0.003 |
| HIA | 0.026 |
| CACO-2 | -5.186 |
| MDCK | 0.000031 |
| BBB | 0.899 |
| PPB | 0.802246 |
| VDSS | 1.991 |
| FU | 0.2979 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.163 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.194 |
| CYP2c9-sub | 0.037 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.347 |
| CYP3a4-inh | 0.252 |
| CYP3a4-sub | 0.754 |
| CL | 12.894 |
| T12 | 0.051 |
| hERG | 0.005 |
| Ames | 0.022 |
| ROA | 0.994 |
| SkinSen | 0.047 |
| Carcinogencity | 0.066 |
| EI | 0.163 |
| Respiratory | 0.987 |
| NR-Aromatase | 0.82 |
| Antiviral | Yes |
| Prediction | 0.822618 |